Long‐term outcome of relapsed acute promyelocytic leukemia treated with oral arsenic trioxide‐based reinduction and maintenance regimens: A 15‐year prospective study - Concepedia

Concepedia

Publication | Open Access

Long‐term outcome of relapsed acute promyelocytic leukemia treated with oral arsenic trioxide‐based reinduction and maintenance regimens: A 15‐year prospective study

DOI Full Paper Access

78

Citations

31

References

2018

Year

Harinder Gill, Rita Yim, Harold K. K. Lee, Vivien Mak, Shek‐Ying Lin, Bonnie Kho, Sze‐Fai Yip, June S. M. Lau, Wah Li, Ho‐Wan Ip,

Abstract

For patients with relapsed APL, As<sub>2</sub> O<sub>3</sub> remained effective despite repeated As<sub>2</sub> O<sub>3</sub> exposures. Oral As<sub>2</sub> O<sub>3</sub> maintenance was an effective postremission strategy for CR2. Cancer 2018;124:2316-26. © 2018 American Cancer Society.

References

	Year	Citations

Page 1